Advertisement

Use of fertility preservation services in female reproductive-aged cancer patients

  • Jessica Selter
    Affiliations
    Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, New York, NY

    New York Presbyterian Hospital, New York, NY
    Search for articles by this author
  • Yongmei Huang
    Affiliations
    Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, New York, NY
    Search for articles by this author
  • Lisa C. Grossman Becht
    Affiliations
    Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, New York, NY

    New York Presbyterian Hospital, New York, NY
    Search for articles by this author
  • Katherine L. Palmerola
    Affiliations
    Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, New York, NY

    New York Presbyterian Hospital, New York, NY
    Search for articles by this author
  • S. Zev Williams
    Affiliations
    Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, New York, NY

    New York Presbyterian Hospital, New York, NY
    Search for articles by this author
  • Eric Forman
    Affiliations
    Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, New York, NY

    New York Presbyterian Hospital, New York, NY
    Search for articles by this author
  • Cande V. Ananth
    Affiliations
    Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY

    Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, New York, NY
    Search for articles by this author
  • Chin Hur
    Affiliations
    Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY

    Herbert Irving Comprehensive Cancer Center, Columbia University College of Physicians and Surgeons, New York, NY

    New York Presbyterian Hospital, New York, NY
    Search for articles by this author
  • Alfred I. Neugut
    Affiliations
    Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY

    Herbert Irving Comprehensive Cancer Center, Columbia University College of Physicians and Surgeons, New York, NY

    Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY

    New York Presbyterian Hospital, New York, NY
    Search for articles by this author
  • Dawn L. Hershman
    Affiliations
    Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY

    Herbert Irving Comprehensive Cancer Center, Columbia University College of Physicians and Surgeons, New York, NY

    Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY

    New York Presbyterian Hospital, New York, NY
    Search for articles by this author
  • Jason D. Wright
    Correspondence
    Corresponding author: Jason D. Wright, MD.
    Affiliations
    Department of Obstetrics and Gynecology, Columbia University College of Physicians and Surgeons, New York, NY

    Herbert Irving Comprehensive Cancer Center, Columbia University College of Physicians and Surgeons, New York, NY

    New York Presbyterian Hospital, New York, NY
    Search for articles by this author

      Objective

      The objective of the study was to determine the rates and predictors of fertility preservation services among reproductive-aged women with common cancers in the United States.

      Study Design

      We used the MarketScan database to identify women 18–45 years of age with lung, breast, colorectal, or cervical cancer who underwent surgery and chemotherapy from 2009 through 2016. Services from 3 months before to 3 months after chemotherapy for evaluation for fertility preservation, laboratory testing for fertility evaluation, and fertility-preserving procedures were captured. Multivariable models were used to assess the factors associated with the use of fertility-preservation services.

      Results

      A total of 18,781 women, including 386 cervical, 1372 colorectal, 246 lung, and 16,777 with breast cancer, were identified. In women 18–35 years old, 11.7% underwent evaluation for fertility preservation, 13.7% underwent laboratory testing, and 6.3% pursued fertility-preserving procedures. The rates of office evaluation, laboratory testing, and performance of procedure were 3.3%, 7.5%, and 1.9 % in women aged 36–40 years and 0.5%, 7.2%, and 0.3% in those aged 41–45 years, respectively. The rate of fertility preservation evaluation rose from 1.0% in 2009 to 5.5% in 2016 (risk ratio, 4.66, 95% confidence interval, 2.38–9.11) while use of fertility-preserving procedures increased from 1.0% to 4.6% (risk ratio, 3.84, 95% confidence interval, 1.94–7.59) during the same time period. In a multivariable model, use of any fertility-preserving interventions were more common in patients with breast cancer (adjusted risk ratio, 2.30, 95% confidence interval, 1.30–4.06), those in the Northeast (adjusted risk ratio, 1.24, 95% confidence interval, 1.10–1.40), and in younger women (18–35 years) (adjusted risk ratio, 2.59, 95% confidence interval, 2.32–2.89).

      Conclusion

      Although limited by lack of information regarding cancer stage and desire for future fertility, only a small fraction of reproductive-aged female cancer patients receiving chemotherapy are evaluated in a nationwide sample for fertility preservation or undergo fertility-preserving procedures.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Obstetrics & Gynecology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Salih S.M.
        • Elsarrag S.Z.
        • Prange E.
        • et al.
        Evidence to incorporate inclusive reproductive health measures in guidelines for childhood and adolescent cancer survivors.
        J Pediatr Adolesc Gynecol. 2015; 28: 95-101
        • Dillon K.E.
        • Gracia C.R.
        Pediatric and young adult patients and oncofertility.
        Curr Treat Options Oncol. 2012; 13: 161-173
        • Trudgen K.
        • Ayensu-Coker L.
        Fertility preservation and reproductive health in the pediatric, adolescent, and young adult female cancer patient.
        Curr Opin Obstet Gynecol. 2014; 26: 372-380
        • Knight S.
        • Lorenzo A.
        • Maloney A.M.
        • et al.
        An approach to fertility preservation in prepubertal and postpubertal females: a critical review of current literature.
        Pediatr Blood Cancer. 2015; 62: 935-939
        • Gilleland Marchak J.
        • Elchuri S.V.
        • Vangile K.
        • Wasilewski-Masker K.
        • Mertens A.C.
        • Meacham L.R.
        Perceptions of infertility risks among female pediatric cancer survivors following gonadotoxic therapy.
        J Pediatr Hematol Oncol. 2015; 37: 368-372
        • Rosen A.
        • Rodriguez-Wallberg K.A.
        • Rosenzweig L.
        Psychosocial distress in young cancer survivors.
        Semin Oncol Nurs. 2009; 25: 268-277
        • Gorman J.R.
        • Su H.I.
        • Roberts S.C.
        • Dominick S.A.
        • Malcarne V.L.
        Experiencing reproductive concerns as a female cancer survivor is associated with depression.
        Cancer. 2015; 121: 935-942
        • Ethics Committee of the American Society for Reproductive Medicine
        Fertility preservation and reproduction in patients facing gonadotoxic therapies: a committee opinion.
        Fertil Steril. 2013; 100: 1224-1231
        • Oktay K.
        • Harvey B.E.
        • Partridge A.H.
        • et al.
        Fertility preservation in patients with cancer: ASCO clinical practice guideline update.
        J Clin Oncol. 2018; 36: 1994-2001
        • Truven Health Analytics
        MarketScan.
        (Available at:)
        • Nattinger A.B.
        • Laud P.W.
        • Bajorunaite R.
        • Sparapani R.A.
        • Freeman J.
        An algorithm for the use of M claims data to identify women with incident breast cancer.
        Health Serv Res. 2004; 39: 1733-1749
        • Kim S.C.
        • Gillet V.G.
        • Feldman S.
        • et al.
        Validation of claims-based algorithms for identification of high-grade cervical dysplasia and cervical cancer.
        Pharmacoepidemiol Drug Saf. 2013; 22: 1239-1244
        • Goldsbury D.
        • Weber M.
        • Yap S.
        • Banks E.
        • O’Connell D.L.
        Identifying incident colorectal and lung cancer cases in health service utilisation databases in Australia: a validation study.
        BMC Med Inform Decis Mak. 2017; 17: 23
        • van Walraven C.
        • Austin P.C.
        • Jennings A.
        • Quan H.
        • Forster A.J.
        A modification of the Elixhauser comorbidity measures into a point system for hospital death using administrative data.
        Med Care. 2009; 47: 626-633
        • Elixhauser A.
        • Steiner C.
        • Harris D.R.
        Comorbidoty measures for use with administrative data.
        Med Care. 1998; 36: 8-27
        • Coding Committee of the American Society for Reproductive Medicine
        Correct coding for laboratory procedures during assisted reproductive technology cycles.
        Fertil Steril. 2016; 105: e5-e8
        • Letourneau J.M.
        • Smith J.F.
        • Ebbel E.E.
        • Craig A.
        • Katz P.P.
        Racial, socioeconomic , and demographic disparities in access to fertility preservation in young women diagnosed with cancer.
        Cancer. 2012; 118: 4579-4588
        • Jenninga E.
        • Hilders C.G.
        • Louwe L.A.
        • Peters A.A.
        Female fertility preservation: practical and ethical considerations of an underused procedure.
        Cancer J. 2008; 14: 333-339
        • Flink D.M.
        • Sheeder J.
        A review of the oncology patient’s challenges for utilizing fertility preservation services.
        J Adolesc Young Adult Oncol. 2017; 6: 31-44
        • Schover L.R.
        • Rybicki L.A.
        • Martin B.A.
        • Bringelsen K.A.
        Having children after cancer: a pilot survey of survivors’ attitudes and experiences.
        Cancer. 1999; 86: 697-709
        • Gorman J.R.
        • Usita P.M.
        • Madlensky L.
        • Pierce J.P.
        Young breast cancer survivors.
        Cancer Nurs. 2011; 34: 32-40
        • Duffy C.M.
        • Allen S.M.
        • Clark M.A.
        Discussions regarding reproductive health for young women with breast cancer undergoing chemotherapy.
        J Clin Oncol. 2005; 23: 766-773
        • Benoit M.
        • Chiles K.
        • Hsieh M.
        The landscape of coverage for fertility preservation in male pediatric patients.
        Urol Pract. 2018; 5: 198-204
        • Knapp C.A.
        • Quinn G.P.
        Healthcare provider perspectives on fertility preservation for cancer patients.
        Cancer Treat Res. 2010; 156: 391-401
        • Lee R.J.
        • Wakefield A.
        • Foy S.
        • Howell S.J.
        • Wardley A.M.
        • Armstrong A.C.
        Facilitating reproductive choices: the impact of health services on the experiences of young women with breast cancer.
        Psychooncology. 2011; 20: 1044-1052
        • Duffy C.
        • Allen S.M.
        • Dube C.
        • Dickersin K.
        Oncologists’ confidence in knowledge of fertility issues for young women with cancer.
        J Cancer Educ. 2012; 27: 369-376